Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Acerca de Lite Strategy

Fundado2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Comunidad
Twitter
Website
Etiquetas
Publicly listed company
Crypto Stocks

Tendencia de cambio del índice de popularidad

Detalles de la recaudación de fondos

Post-IPO(2025-07-21)
Cantidad€86,62M
Valuación--